Empagliflozin Tablets 10 mg (Empagliflozin)

Adult dose

The recommended dosage of this medication is 10 mg once daily for both monotherapy and additional combination therapy with other blood glucose-lowering agents such as insulin. If the patient has good tolerability and additional blood glucose control is required, the dosage can be increased to 25 mg once daily. This medication can be taken regardless of meals, and the tablet should be swallowed whole. If a dose is missed, take it as soon as remembered, but do not take two doses on the same day.

This medication should not be used in patients with allergies to the active ingredient or other components. It should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. This medication is not used in patients with severely impaired kidney function or those undergoing dialysis. Patients with lactose intolerance or certain genetic metabolic disorders should not be given this medication. For patients with slightly impaired kidney function, dose adjustment is necessary, and treatment should be discontinued if function worsens. It should be used cautiously in some heart failure patients and is not recommended for those with severe heart failure. When this medication is used with insulin or insulin secretagogues, there may be a risk of hypoglycemia, so dose adjustments may be needed. This medication can cause side effects such as hypoglycemia, urinary tract infections, genital fungal infections, and increased urination, so caution is advised. Particularly, fluid volume depletion or dehydration symptoms may occur, so elderly patients or those with low blood pressure need to be especially careful. Serious metabolic disorders such as ketoacidosis can occur, so immediate treatment is required if symptoms appear. Cases of liver damage have been reported, so patients with liver function abnormalities need to be cautious. It is recommended not to use this medication during pregnancy, and breastfeeding should be discontinued if the mother is using this drug. Safety and efficacy in children under 18 years have not been established. In the case of overdose, appropriate treatment is necessary, and methods to remove this medication via blood dialysis are not known. This medication may interact with other drugs, so consult a healthcare professional if other medications are being taken. Caution is necessary when driving or operating machinery due to the risk of hypoglycemia. Diabetes patients should pay attention to everyday foot care, as rare severe infections such as perineal necrosis may occur, so symptoms should be carefully monitored.

Serious side effects

Hives, angioedema, chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, severe rash with fever, blistering, skin peeling, oral/ocular mucosal pain, severe skin reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory issues with cough and fever, respiratory problems, yellowing of the skin or eyes (jaundice), severe malaise, liver abnormalities (jaundice), sudden and severe

Mild side effects

• Vulvovaginal candidiasis
• vulvovaginitis
• balanitis and other genital infections
• hypoglycemia
• increased urination
• rash
• itching
• increased serum lipids
• increased blood creatinine
• decreased glomerular filtration rate

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is best to keep the storage temperature between 1 and 30 degrees Celsius to maintain the drug's efficacy and safety.

Appearance

Light yellow, double-sided convex round film-coated tablet

Package unit

30 tablets/bottle